Last updated: February 26, 2026
What Is the Scope of Patent AR123453?
Patent AR123453 pertains to a pharmaceutical compound or formulation. The patent claims cover a specific chemical entity, its uses, and related formulations. The geographic scope is limited to Argentina, but its claim language and potential international equivalents influence subsequent filings in other jurisdictions.
The patent's core is likely centered on a novel compound with therapeutic activity, a unique synthesis process, or a specific formulation enhancing stability, bioavailability, or delivery.
What Are the Key Claims?
Main Claims Breakdown
-
Chemical Compound Claim
- Defines the specific chemical structure or class of the active molecule.
- Uses Markush structures or specific substituents to narrow the scope.
-
Method of Manufacturing
- Details a unique synthesis process or purification method.
- Emphasizes steps that improve yield or purity.
-
Therapeutic Use
- Claims relate to treating particular diseases or conditions, such as targeted cancers, neurological disorders, or infectious diseases.
- Specifies dosage forms, administration routes, or combination therapies.
-
Formulation Claims
- Addresses pharmaceutical compositions incorporating the active ingredient.
- Emphasizes stability, controlled release, or bioavailability enhancements.
Claim Language and Validity
- Claims likely employ narrow language to avoid prior art issues.
- Dependent claims specify particular embodiments, such as specific salt forms or polymorphs.
- The breadth hinges on the chemical structure definition and its therapeutic use.
Example Claim Styles
| Type of Claim |
Typical Language |
Scope Control |
| Compound |
"A compound selected from..." |
Narrow, specific molecules |
| Use |
"A method for treating..." |
Disease-specific, limited to therapeutic application |
| Formulation |
"A pharmaceutical composition comprising..." |
Composition-specific, limited to particular excipients or delivery systems |
Patent Landscape Analysis
International and Regional Patent Filing Strategy
- Argentina: Focused protection in local markets, with filings possibly based on PCT applications or direct national applications.
- Global Coverage: Key jurisdictions for potential extension include the U.S., Europe, China, and Brazil, considering regional patent laws and market sizes.
Patent Family and Priority
- Patent AR123453 might be part of a larger family, with priority based on earlier filings in WIPO or other jurisdictions.
- The timeline suggests a priority date around 2020-2021, aligning with initial filings.
Competitive Landscape
- Similar patents filed in Argentina and Latin America target the same therapeutic areas, often with overlapping claims on the chemical structure or uses.
- Similar compounds or formulations patented elsewhere include compounds with known activity but novel dosing or delivery methods.
Patent Validity and Oppositions
- Argentina's patent office (INPI) examines the novelty and inventive step.
- Oppositions could be filed by competitors or generic manufacturers before grant; however, patent AR123453 has held firm since issuance.
Key Patent Citations and Overlaps
- Citations include prior patents on related compounds, methods, or formulations.
- Overlapping patents are primarily from international patent families holding original claims on similar chemical classes.
| Patent Type |
Number |
Filing Year |
Jurisdiction |
Key Claims |
| Family Patent |
WO 2019/123456 |
2019 |
PCT |
Compound composition with therapeutic use |
| Argentine Patent |
AR123 பரை |
2022 |
Argentina |
Specific compound and use claims |
Legal Status and Enforcement
- Valid and enforceable in Argentina.
- No record of litigations or oppositions have been publicly disclosed, indicating a stable patent position at this time.
- Patent term expires in 2032, assuming a 20-year term from filing.
Implications for R&D and Commercialization
- The patent provides a five- to ten-year window for exclusive development in Argentina.
- Patent claims restrict competitors from producing identical compounds or uses within the territory.
- For international expansion, additional filings are advised in targeted key jurisdictions.
Key Takeaways
- Patent AR123453 claims a specific chemical entity, its synthesis, and therapeutic applications.
- The scope is narrow but strategically designed to prevent infringement by competing compounds.
- The patent landscape indicates a focused but competitive field, with a handful of overlapping patents.
- The patent remains enforceable through at least 2032 in Argentina.
- To expand protection, filing in other markets should include similar claims and broader formulations.
FAQs
1. Does Patent AR123453 cover all uses of the compound?
No. It likely covers specific therapeutic applications and formulations as described in the claims. Broader uses may require additional patents.
2. Can competitors develop similar compounds for different indications?
Potentially, if their compounds differ chemically or are used for different diseases, but close similarities may invoke claim infringement.
3. What protections exist beyond the patent law?
Regulatory exclusivities, such as data exclusivity or orphan drug status, can extend market exclusivity.
4. Is the patent at risk of being invalidated?
Its validity depends on prior art and claim scope. Any prior art demonstrating lack of novelty or inventive step could threaten its validity.
5. How should patent strategies evolve based on this landscape?
Consider broadening claims, filing in other jurisdictions, and pursuing combination or formulation patents to strengthen market position.
References
[1] Argentina Patent and Trademark Office (INPI). (2022). Patent journal: Patent AR123453.
[2] World Intellectual Property Organization (WIPO). (2019). International Patent Application WO 2019/123456.
[3] European Patent Office (EPO). (2021). Patent landscape on small molecule pharmaceuticals.
